GL1X · GenesisL1 explorer

Research workbench

Refinement of human lysozyme at 1.5 ångströms resolution. analysis of non-bonded and hydrogen-bond interactions

Analyse Refinement of human lysozyme at 1.5 ångströms resolution. analysis of… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1LZ1
Type
protein
Length
130 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human lysozyme
EC
3.2.1.17
UniProt
P61626
Pockets
1 · best druggability 0.32

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHuman lysozyme (EC 3.2.1.17)protein13039% helix, 12% strandP61626

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1720.320.7516empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1LZ1 · Refinement of human lysozyme at 1.5 ångströms resolution. analysis of non-bonded and… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.